Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study
Resource Type
Article
Authors
Heppner, DG ; Kemp, TL ; Martin, BK ; Ramsey, WJ ; Nichols, R ; Dasen, EJ ; Fusco, J ; Crowell, J ; Link, C ; Creager, J ; Monath, TP ; Das, R ; Xu, ZJ ; Klein, R ; Nowak, T ; Gerstenberger, E ; Bliss, R ; Sheldon, EA ; Feldman, RA ; Essink, Brandon J ; Smith, WB ; Chu, L ; Seger, WM ; Saleh, J ; Borders, JL ; Adams, M ; Heppner, D Gray, Jr ; Kemp, Tracy L ; Martin, Brian K ; Ramsey, William J ; Nichols, Richard ; Dasen, Emily J ; Link, Charles J ; Das, Rituparna ; Xu, Zhi Jin ; Sheldon, Eric A ; Nowak, Teresa A ; Monath, Thomas P
Source
In The Lancet Infectious Diseases August 2017 17(8):854-866
Subject
Primary Research Articles
Language
ISSN
1473-3099